These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8663300)

  • 1. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2.
    Chai YC; Howe PH; DiCorleto PE; Chisolm GM
    J Biol Chem; 1996 Jul; 271(30):17791-7. PubMed ID: 8663300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.
    Chai YC; Binion DG; Macklis R; Chisolm GM
    Vascul Pharmacol; 2002 Apr; 38(4):229-37. PubMed ID: 12449019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.
    Murugesan G; Fox PL
    J Clin Invest; 1996 Jun; 97(12):2736-44. PubMed ID: 8675684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by eicosapentaenoic acid of oxidized-LDL- and lysophosphatidylcholine-induced human coronary artery smooth muscle cell production of endothelin.
    Kohno M; Ohmori K; Wada Y; Kondo I; Noma T; Fujita N; Mizushige K; Mandal AK
    J Vasc Res; 2001; 38(4):379-88. PubMed ID: 11455209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phospholipase A2 in expression of the scavenger pathway in cultured aortic smooth muscle cells stimulated with phorbol 12-myristate 13-acetate.
    Morisaki N; Yokote K; Takahashi K; Otabe M; Saito Y; Yoshida S; Ueda S
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):247-53. PubMed ID: 7945248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL.
    Hsieh CC; Yen MH; Liu HW; Lau YT
    Atherosclerosis; 2000 Aug; 151(2):481-91. PubMed ID: 10924725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    Circulation; 2001 Jul; 104(1):16-8. PubMed ID: 11435331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells.
    Yoon BK; Kang YH; Oh WJ; Park K; Lee DY; Choi D; Kim DK; Lee Y; Rhyu MR
    J Korean Med Sci; 2012 Jul; 27(7):803-10. PubMed ID: 22787379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C.
    Sugiyama S; Kugiyama K; Ohgushi M; Fujimoto K; Yasue H
    Circ Res; 1994 Apr; 74(4):565-75. PubMed ID: 8137494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
    Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
    Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.
    Watanabe T; Takahashi K; Kanome T; Hongo S; Miyazaki A; Koba S; Katagiri T; Pakara R; Benedict CR
    Hypertens Res; 2006 Oct; 29(10):821-31. PubMed ID: 17283870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL.
    Ohgushi M; Kugiyama K; Fukunaga K; Murohara T; Sugiyama S; Miyamoto E; Yasue H
    Arterioscler Thromb; 1993 Oct; 13(10):1525-32. PubMed ID: 8399090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.
    Stiko-Rahm A; Hultgårdh-Nilsson A; Regnström J; Hamsten A; Nilsson J
    Arterioscler Thromb; 1992 Sep; 12(9):1099-109. PubMed ID: 1326320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway.
    Sugiyama S; Kugiyama K; Ogata N; Doi H; Ota Y; Ohgushi M; Matsumura T; Oka H; Yasue H
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):568-76. PubMed ID: 9555862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis.
    Stiko A; Regnström J; Shah PK; Cercek B; Nilsson J
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):194-200. PubMed ID: 8620332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    J Hypertens; 2001 Jun; 19(6):1065-73. PubMed ID: 11403355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation.
    Chen L; Liang B; Froese DE; Liu S; Wong JT; Tran K; Hatch GM; Mymin D; Kroeger EA; Man RY; Choy PC
    J Lipid Res; 1997 Mar; 38(3):546-53. PubMed ID: 9101435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Koba S; Katagiri T; Benedict CR
    Circulation; 2001 Mar; 103(10):1440-5. PubMed ID: 11245650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors.
    Murohara T; Scalia R; Lefer AM
    Circ Res; 1996 May; 78(5):780-9. PubMed ID: 8620597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.